Human Cyclin Dependent Kinase Inhibitor 2A (CDKN2A) ELISA Kit

Quantitative measurement of the CDKN2A tumor suppressor protein supports research into cell cycle regulation, oncogenesis, and biomarker discovery. This ELISA kit from Assay Genie is configured for use with human samples including tissue homogenates, cell lysates, and other research specimens, making it a practical tool for laboratories studying cancer pathways, cellular senescence, and proliferative disorders.

The p16INK4a protein encoded by CDKN2A is a key cyclin-dependent kinase inhibitor that regulates the G1 to S phase transition, and quantitative detection in research samples helps characterize tumor suppressor status in patient-derived tissues and model systems. Researchers investigating melanoma, pancreatic cancer, glioblastoma, and other malignancies with frequent CDKN2A alterations can incorporate this kit into workflows that require reproducible quantification across many specimens, including lysates prepared from cultured cell lines.

Standard assay workflow uses a microplate reader with appropriate filters, and reagents are provided in sufficient quantity for the stated assay count. Storage conditions follow the manufacturer's stability guidelines, and the kit is intended for research use only in laboratory settings studying cell cycle checkpoints, tumor biology, and related translational questions.